A carregar...
Ziprosidone-Induced Transient Agranulocytosis; Delayed Onset of Cardiac Adverse Effects with Fingolimod; Telmisartan-Induced Myotoxicity; Severe Dilated Cardiomyopathy Induced by Adalimumab and Ustekinumab
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA’s) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWa...
Na minha lista:
| Publicado no: | Hosp Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Thomas Land Publishers, Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5057190/ https://ncbi.nlm.nih.gov/pubmed/27729671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5010-855 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|